During the past decade, Städtisches Klinikum Braunschweig gGmbH conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 13 clinical trials were completed, i.e. on average, 23.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 10 clinical trials were completed. i.e. 43.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Städtisches Klinikum Braunschweig gGmbH" #1 sponsor was "University of Ulm" with 10 trials, followed by "Astex Pharmaceuticals, Inc." with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 55 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Städtisches Klinikum Braunschweig gGmbH" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Astellas Pharma Inc" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator and "ICON plc" with 2 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Städtisches Klinikum Braunschweig gGmbH" are "Acute Myeloid Leukemia" (14 trials), "Acute Myeloid Leukemia (AML)" (5 trials), "Myelodysplastic Syndromes" (5 trials), "Leukemia" (4 trials) and "Lymphoma" (4 trials). Many other conditions were trialed in "Städtisches Klinikum Braunschweig gGmbH" in a lesser frequency.

Most popular intervention types in "Städtisches Klinikum Braunschweig gGmbH" are "Drug" (69 trials), "Biological" (11 trials), "Radiation" (9 trials), "Device" (8 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Cytarabine" (9 trials), "cyclophosphamide" (7 trials), "doxorubicin hydrochloride" (6 trials) and "radiation therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Städtisches Klinikum Braunschweig gGmbH" are 74 trials for "All" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Städtisches Klinikum Braunschweig gGmbH". undefined are not yet recruiting, 20 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Städtisches Klinikum Braunschweig gGmbH, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Städtisches Klinikum Braunschweig gGmbH, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Städtisches Klinikum Braunschweig gGmbH has several departments that took part in Clinical trials: "Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie" - 3 trials